This study is in progress, not accepting new patients
An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related Leukodystrophy
Summary
- Location
- at UCSD
- Dates
- study startedstudy ends around
- Principal Investigator
- by Olivia Kim-McManus (ucsd)
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Olivia Kim-McManus (ucsd)
Dr. Olivia Kim-McManus is an Associate Clinical Professor at UC San Diego School of Medicine Department of Neurosciences and a pediatric neurologist and epileptologist at Rady Children's Hospital Division of Pediatric Neurology.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT07222371
- Phase
- Phase 1/2 TUBB4A-Related Leukodystrophy Research Study
- Study Type
- Interventional
- Participants
- About 1 people participating
- Last Updated